ALK Rearrangement Adenocarcinoma with Histological Transformation to Squamous Cell Carcinoma Resistant to Alectinib and Ceritinib

Specific tyrosine-kinase inhibitors (TKIs) are widely used for the treatment of non-small-cell lung cancers with anaplastic lymphoma kinase (ALK) translocations. However, most treated patients eventually develop resistance to the TKIs. The histological transformation into small cell carcinoma is wel...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: Kaiho, Taisuke, Nakajima, Takahiro, Iwasawa, Shunichiro, Yonemori, Yoko, Yoshino, Ichiro
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2020
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7039243/
https://ncbi.nlm.nih.gov/pubmed/32110052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S236706
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky